A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma
- Resource Type
- article
- Source
- Genes and Diseases, Vol 10, Iss 6, Pp 2241-2244 (2023)
- Subject
Medicine (General) R5-920 Genetics QH426-470 - Language
- English
- ISSN
- 2352-3042